diabetestalk.net

Berberine: A Supplement For Diabetes As Good As A Drug?

Berberine: A Supplement for Diabetes as Good as a Drug?

Berberine: A Supplement for Diabetes as Good as a Drug?


Berberine: A Supplement for Diabetes as Good as a Drug?
Berberine: A Supplement for Diabetes as Good as a Drug?
The Centers for Disease Control and Prevention (CDC) has declared diabetes an American epidemic with more than 25 million Americans afflicted with diabetes. Another 80 million are classified prediabetic, per the American Diabetes Association. The numbers get even bigger when you put a dollar sign in front of them: As of 2012, $245 billion a year was being spent on diabetes in the U.S., including $176 billion in direct medical costs and the rest -- $69 billion in lost productivity.
Its no wonder that pharmaceutical companies remain fully engaged in diabetes-related research, devising new medications and enhancing the older ones looking for a cure. Among the drugs now being used for type 2 diabetes are metformin, sulfonylureas (which goes by the trade names Diabeta and Glucotrol, among others) and DPP-5 inhibitors (Januvia, Tradienta, etc.). All have been shown to be effective to one degree or another, but the epidemic continues to beg for new and improved drugs.
One of the great new hopes in the world of diabetes treatment is a natural plant-based compound that has been used for thousands of years in traditional Chinese and Ayurvedic medical practice. However, it has only become a part of Western medicine in recent years. Most of the attention on berberine, at least in the U.S., encompasses only the 21st century. In that sense, our newest discovery means we are just now catching up with the rest of the world.
Note to readers: Wonder Labs will have a special Continue reading

Rate this article
Total 1 ratings
Long-Term Benefits of Linoleic Acid In Type 2 Diabetes

Long-Term Benefits of Linoleic Acid In Type 2 Diabetes


Home / Conditions / Type 2 Diabetes / Long-Term Benefits of Linoleic Acid In Type 2 Diabetes
Long-Term Benefits of Linoleic Acid In Type 2 Diabetes
High linoleic acid level could reduce type 2 risk by 43 percent, new study found.
Polyunsaturated fatty acids such as omega-3 and omega-6 fatty acids are beneficial for improving lipid profiles in healthy individuals and among patients with type 2 diabetes.
Supplementation with omega-3 fatty acids lowers triglycerides and VLDL cholesterol, but they might also increase LDL cholesterol. Latest evidences suggest omega-3 fatty acids are not related to mortality, hypertension, cardiovascular disease as well as the risk of microvascular complications in patients with type 2 diabetes. Meanwhile, the metabolic effects of omega-6 fatty acids remain largely unknown and there is little available evidence regarding their potential role in the prevention of type 2 diabetes. A pooled analysis of international studies was assessed to find the associations of linoleic acid and arachidonic acid biomarkers with incident type 2 diabetes.
Researchers analyzed data from 20 prospective cohort studies from ten countries, including Iceland, Netherlands, United States, Taiwan, United Kingdom, Germany, Finland, Australia, Sweden, and France. All included study participants were between 49-76 years old with a body mass index of 23.328.4 kg/m2 and had data for linoleic acid and arachidonic acid biomarkers at baseline. Any participants with type 2 diabetes at baseline were excluded from the study. Researchers defined incident type 2 diabetes as havin Continue reading

Diabetes and Alcohol: to drink or not to drink

Diabetes and Alcohol: to drink or not to drink


Diabetes and Alcohol: to drink or not to drink
The life of a diabetic is full of challenges and they have to face it in each and every day of their lives. Each day seems like a struggle and this tussle takes a heavy toll on diabetic physically and emotionally.
Signup now and receive an email once I publish new content.
I will never give away, trade or sell your email address. You can unsubscribe at any time.
One of the major concern among diabetic is what kind of items they can have and what needs to be avoided. And with this problem, a question arises of diabetes and alcohol relationship;
Are they prone to more risk of complication with alcohol?
What is the safe limit for a diabetic to have alcohol?
A large chunk of population consume alcohol in some form or another;
Consumption of alcohol is only rising due to stressful life and increased depression related cases;
Our films have also promoted alcohol intake, they have developed a sense of perception that late night partying and boozing around is a way for happy and successful life;
Reports claiming health benefits of alcohol have confused people whether it is good or bad for health;
Before coming to a straight answer, we should understand how our body reacts with alcohol intake.
The food we eat get metabolize and digested in thestomach.
But the case is different with alcohol; our liver is responsible for Alcohol metabolism.
1. It stores and secretes glucose to cells in order to fuel them when we are not eating
So whenever we take alcohol, it is not considered as food by our stomach but identified as toxic Continue reading

Device Connectivity  The Next Big Wave in Diabetes

Device Connectivity The Next Big Wave in Diabetes


Device Connectivity The Next Big Wave in Diabetes
The Apple Watch and its operating system iOS 8 holds great promise for people with diabetes when it and the iPhone finally connect wearers to Apples Health software. With Android options also rapidly developing, these advances hold great potential for easy passage of diabetes data between devices so it can benefit people with diabetes and their health care providers. The question we really want answered is when will the meter, pump and CGM talk to each other?
The Apple Watch and its operating system iOS 8 holds great promise for people with diabetes when it and the iPhone finally connect wearers to Apples Health software. With Android options also rapidly developing, these advances hold great potential for easy passage of diabetes data between devices so it can benefit people with diabetes and their health care providers. The question we really want answered is when will the meter, pump and CGM talk to each other?
Connectivity is the coming big wave in diabetes, offering better tools to solve the ongoing problems of high A1cs, variable blood sugars, and hypoglycemia. Advances in health care are now being brought about not only by clinicians or pharmaceutical companies but by telecommunication and software developers. Connectivity will make glucose control more accessible, more affordable, and bring greater clarity to day-to-day interventions.
Tracking a wealth of data such as glucose readings, glucose trend lines, calorie and carb intake, activity levels, weight, and blood pressure is critical in diabetes care, yet co Continue reading

Is Glaucoma a Neurodegeneration caused by Central Insulin Resistance: Diabetes Type 4?

Is Glaucoma a Neurodegeneration caused by Central Insulin Resistance: Diabetes Type 4?


Is Glaucoma a Neurodegeneration caused by Central Insulin Resistance: Diabetes Type 4?
We are experimenting with display styles that make it easier to read articles in PMC. The ePub format uses eBook readers, which have several "ease of reading" features already built in.
The ePub format is best viewed in the iBooks reader. You may notice problems with the display of certain parts of an article in other eReaders.
Generating an ePub file may take a long time, please be patient.
Jaypee Brothers Medical Publishing (P) Ltd.
Is Glaucoma a Neurodegeneration caused by Central Insulin Resistance: Diabetes Type 4?
How to cite this article: Dada T. Is Glaucoma a Neurodegeneration caused by Central Insulin Resistance: Diabetes Type 4? J Curr Glaucoma Pract 2017;11(3):77-79.
Glaucoma is an acquired multifactorial progressive neurodegenerative syndrome with complex pathogenesis. It is characterized by accelerated retinal ganglion cell (RGC) apoptosis and leads to optic neuropathy with visual field defects, the intraocular pressure (IOP) being a major risk factor. The only therapy currently available is lowering of IOP with medical/laser/surgical therapy; however, many patients continue to progress despite an adequately controlled or apparently normal IOP. Recent studies have shown that glaucoma patients have central neurodegenera-tion involving both the occipital cortex and lateral genicu-late body (LGB). 1 , 2 It has been postulated that glaucoma may be a disease initially affecting the central nervous system (CNS) and traveling dow Continue reading

No more pages to load

Popular Articles

  • Metformin diabetes drug could extend lifespan

    Metformin is approved in the US as a treatment for type 2 diabetes. A new study by Cardiff University, UK, involving over 180,000 people, reveals that the drug could also increase the lifespan of those individuals who are non-diabetics. According to the Centers for Disease Control and Prevention (CDC), there are around 29.1 million people in the US with diabetes, equating to 9.3% of the population ...

  • The Diabetes Drug That Could Be an Anti-Aging Miracle

    In a slew of recent flashy endeavors, scientists, academics and exceptionally rich people have taken on the aging process. In 2013, Google launched Calico, its billion-dollar anti-aging research and development arm, which the following year formed a partnership with pharmaceutical giant AbbVie. Meanwhile, another major drug company, Novartis, is developing a patentable form of rapamycin—a biolog ...

  • Cancer Drug Gleevec Might Slow Type-1 Diabetes

    Gleevec, the daily pill that turned a killer type of leukemia into a manageable disease, may also help slow the worsening of diabetes, researchers reported Monday. In a follow up to a 2008 study in which diabetic mice were cured by the drug, a team reports “modest” effects in adults with type-1 diabetes. This is the type of diabetes often called juvenile diabetes and it’s caused when the imm ...

  • Could a Diabetes Drug Help Beat Alzheimer's Disease?

    Most of the 20 million people diagnosed with type 2 diabetes in the U.S. take metformin to help control their blood glucose. The drug is ultrasafe: millions of diabetics have taken it for decades with few side effects beyond gastrointestinal discomfort. And it is ultracheap: a month's supply costs $4 at Walmart. And now new studies hint that metformin might help protect the brain from developing d ...

  • Diabetes WONDER DRUG: New pill can 'significantly' improve health of Type 2 sufferers

    British researchers have shown a simple pill has the power to lower blood sugar and promote weight loss in just three months. The development is significant as the once a day tablet could potentially end the need for painful daily insulin injections. And it comes as figures show the diabetes epidemic gripping the UK costs the NHS more than £10 billion a year with a new diagnosis made every two mi ...

  • U.S. FDA approves new diabetes drug from Merck and Pfizer

    (Reuters) - A new drug developed by Merck & Co and Pfizer Inc won U.S. approval on Wednesday to treat type II diabetes, the Food and Drug Administration said, adding another competitor to a growing class of treatments. The oral drug, known generically as ertugliflozin, will be sold under the brand name Steglatro and compete with AstraZeneca Plc’s Farxiga, Johnson & Johnson’s Invokana and Eli L ...

  • Doctors debate danger of popular diabetes drug after FDA amputation warning

    Many San Diego doctors are taking their patients off of Invokana, a widely used diabetes drug, after a large industry-sponsored trial found it doubled the risk of lower limb amputations compared with those taking a placebo. With 23.1 million people in the U.S. diagnosed with diabetes, many of them are taking newer drugs to control glucose. But new research involving one of those drugs, Invokana, s ...

  • Diabetes drug counters weight gain associated with autism medicines

    Study offers hope for children and teens who struggle with common a side effect of medications for reducing autism-associated agitation In a small new study, a commonly used diabetes drug curbed the troublesome weight gain that is a common side effect of the only two medicines approved for reducing agitation in children and teens with autism. The promising results of the study – which took place ...

  • A New Drug May Be Able to Completely Reverse Diabetes

    Scientists have used a new drug to reverse diabetes in mice. The drug inhibits the enzyme LMPTP, which contributes to the development of Type 2 diabetes by weakening the body's sensitivity to the hormone. Defining Diabetes In the global community, the number of people with diabetes has been on the rise since 1980, with 422 million people diagnosed by 2014. The U.S. alone has experienced a substant ...

Related Articles